SEC Form 4 · accession 0001645627-17-000095
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jul 17, 2017
Accepted (ET)
Jul 20, 2017 · 3:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 17, 2017 | P | 2,000 | $0.0269 | A | 21,671,819 | D | |
| Common Stock | Jul 17, 2017 | P | 5,000 | $0.0269 | A | 21,676,819 | D | |
| Common Stock | Jul 17, 2017 | P | 2,000 | $0.027 | A | 21,678,819 | D | |
| Common Stock | Jul 17, 2017 | P | 5,000 | $0.028 | A | 21,683,819 | D | |
| Common Stock | Jul 17, 2017 | P | 2,000 | $0.0288 | A | 21,685,819 | D | |
| Common Stock | Jul 17, 2017 | P | 5,000 | $0.028 | A | 21,690,819 | D | |
| Common Stock | Jul 17, 2017 | P | 2,000 | $0.0269 | A | 21,692,819 | D | |
| Common Stock | Jul 17, 2017 | P | 5,000 | $0.0269 | A | 21,697,819 | D | |
| Common Stock | Jul 17, 2017 | P | 5,000 | $0.0269 | A | 21,702,819 | D | |
| Common Stock | Jul 17, 2017 | P | 2,000 | $0.0268 | A | 21,704,819 | D | |
| Common Stock | Jul 17, 2017 | P | 2,000 | $0.0268 | A | 21,706,819 | D | |
| Common Stock | Jul 17, 2017 | P | 2,000 | $0.0268 | A | 21,708,819 | D |
Table II — derivative securities
No Table II lines on this filing.